A2 Biotherapeutics, Inc.

A2 Biotherapeutics, Inc.

Biotechnology Research 30301 Agoura Road 123 employees
Employees
123
Contacts
3
Emails
3

A2 Biotherapeutics, Inc. Overview

Headquarters
30301 Agoura Road
Industry
Biotechnology Research
Employees
123
Founded
2018
Funding
300.0K
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About A2 Biotherapeutics, Inc.

A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. A2 engineers T cells that target the loss of genetic material in tumors, enabling the selective killing of tumor cells while leaving normal cells unharmed. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and has raised $136M since inception. Our investors include The Column Group, Vida Ventures, Samsara BioCapital, Nextech Invest, Casdin Capital, Euclidean Capital, UC Investments (Office of the Chief Investment Officer of the Regents) and Hartford HealthCare Endowment.

A2 Biotherapeutics, Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage

A2 Biotherapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Jakob Loven, Phd
View
Paul Salim Senior Manager, Manufacturing at A2
Email
Helen S. Kim
Email
William Cleary
Email

Employees by Management Level

Manager 7 profiles
Director 4 profiles
Individual contributor 4 profiles
Executive 1 profile
VP / Head 1 profile
Senior / Lead 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 5 5 2
Executive 3 3 2
HR 1 1 1
IT 1 1 0

A2 Biotherapeutics, Inc. Tech Stack

Data / AI 3 profiles
Engineering 2 profiles

Compare Similar Companies to A2 Biotherapeutics, Inc.